This article compares amendment of patent applications before the USPTO and the European Patent Office (EPO), focussing on the differences in law and practice between these jurisdictions. Adaptation of a PCT application for regional phase entry in each jurisdiction is also discussed. References are made to the EPO Guidelines, which is the main source for European Patent Office practice. Some guidance is also provided on differences between claim interpretation in Europe and the US.
Richard Lawrence 13 June 2019
This article was first published (as “Amendment in Europe and the US”) on 12/2018 by Bloomberg Law. Reproduced with permission from Bloomberg Law, https://www.bna.com/bloomberglaw. Copyright (c) 2018 by The Bureau of National Affairs, Inc, https://www.bna.com/